Patents by Inventor Arundutt Viswanatham Silamkoti

Arundutt Viswanatham Silamkoti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Patent number: 7592359
    Abstract: This invention generally relates to derivatives of substituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: September 22, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Arundutt Viswanatham Silamkoti, Jang Bahadur Gupta
  • 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Patent number: 7560479
    Abstract: This invention relates to derivatives of 3,6-disubstituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: July 14, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Arundutt Viswanatham Silamkoti, Jang Bahadar Gupta
  • 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
    Patent number: 7232835
    Abstract: This invention relates to derivatives of 3,6-disubstituted azabicyclo compounds. The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: June 19, 2007
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Arundutt Viswanatham Silamkoti, Bruhaspathy Miriyala, Sudershan Kumar Arora, Boju Srinivasulu, Bireshwar Mukherjee, Jang Bahadur Gupta